Spatial Genomics and Transcriptomics Report 2025 – For Strategy Officers and Market Intelligence Teams

June 18, 2025 06:03 PM AEST | By EIN Presswire
 Spatial Genomics and Transcriptomics Report 2025 – For Strategy Officers and Market Intelligence Teams
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 18, 2025 /EINPresswire.com/ -- What Is The Growth Trajectory Of The Spatial Genomics And Transcriptomics Market?

The spatial genomics and transcriptomics market size has been growing rapidly in recent years. From $1.51 billion in 2024, it is projected to reach $1.70 billion in 2025, charting a compound annual growth rate CAGR of 12.7%. This substantial growth in the historic period can be attributed to major factors such as the rise of single-cell genomics, increased funding for cancer research, the growth of bioinformatics infrastructure, the burgeoning demand for precision medicine, and a general surge in pharmaceutical research and development.

What Does the Future Hold for the Spatial Genomics and Transcriptomics Market?

The market size for spatial genomics and transcriptomics is predicted to show brisk growth in the forthcoming years. It is set to reach $2.72 billion in 2029, registering a CAGR of 12.4%. This forecasted growth can be credited to the growing necessity for early disease detection, the increase in biomarker discovery, regulatory backing for advanced diagnostics, the mounting acceptance of personalized medicine, and the intensification of cancer research. Advancements in sequencing technologies, artificial intelligence and machine learning integration, innovation in data processing and visualization solutions, advancements in data storage and analysis tools, and collaborations and consortia are some key trends expected during the forecast period.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24405&type=smp

What Is Driving The Spatial Genomics And Transcriptomics Market Growth?

It is anticipated that the increasing adoption of personalized medicine will act as a significant growth driver for the spatial genomics and transcriptomics market. With genetics, lifestyle, and environmental factors tailored to each patient, personalized medicine enhances treatment effectiveness and minimizes side effects. The demand for personalized medicine is on the rise, as advancements in genetic research enable more precise treatments tailored to an individual’s unique genetic makeup, leading to more favorable patient outcomes. Spatial genomics and transcriptomics plays a pivotal role in personalizing medicine by uncovering the precise location and activity of genes within tissues. This facilitates targeted, individualized treatment strategies based on a patient’s unique molecular landscape.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/spatial-genomics-and-transcriptomics-global-market-report

Who Are The Key Players Operating In The Spatial Genomics And Transcriptomics Market?

Key players in the industry, like Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Bio-Techne Corporation, 10x Genomics Inc., Standard BioTools Inc., Akoya Biosciences Inc., Seven Bridges Genomics, Vizgen Inc., Lunaphore Technologies SA., Parse Biosciences, Indica Labs Inc., Resolve Biosciences GmbH., RareCyte Inc., Ionpath Inc., Dovetail Genomics, S2 Genomics Inc., BioSpyder Technologies Inc., are championing the development and growth of the spatial genomics and transcriptomics market.

What Major Trends Are Fueling The Growth Of The Spatial Genomics And Transcriptomics Market?

Major companies in the spatial genomics and transcriptomics market are concentrating on developing innovative solutions such as spatial transcriptomics technologies. These advanced techniques map gene expression across tissue samples while preserving their spatial context, empowering researchers to study the location and distribution of RNA molecules within tissues. These groundbreaking technologies significantly augment our understanding of gene expression in the context of tissue architecture.

How Is The Spatial Genomics And Transcriptomics Market Segmented?

This robust growth in the global market comes with a complex segmentation framework. The market is divided based on product into Instruments, Consumables, and Software. It is further segmented by technology into Spatial Transcriptomics, Sequencing-Based Methods, Immunohistochemistry IHC, Microscopy-Based RNA Imaging Techniques, and Spatial Genomics. It is also categorized by application and includes Diagnostics, Translation Research, Drug Discovery And Development, Single Cell Analysis, Cell Biology, and Other Applications. The end-users segment encompasses Pharmaceutical And Biotechnology Companies, Contract Research Organizations, and Academic And Research Institutes.

How Is The Spatial Genomics And Transcriptomics Market Spread Globally?


In 2024, North America was leading as the largest region in the spatial genomics and transcriptomics market. However, the Asia-Pacific region is hoping to outpace it as the fastest-growing region in the upcoming forecast period. The regions covered in this report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Geospatial Solutions Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/geospatial-solutions-global-market-report

Geospatial Imagery Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/geospatial-imagery-analytics-global-market-report

Geospatial Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/geospatial-analytics-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.